Literature DB >> 14500116

Distinct serial position profiles and neuropsychological measures differentiate late life depression from normal aging and Alzheimer's disease.

Nancy S Foldi1, Adam M Brickman, Lynn A Schaefer, Margaret E Knutelska.   

Abstract

Geriatric depression is associated with cognitive deficits that share similar features with Alzheimer's disease (AD) and normal aging. This study examined cognitive profiles and serial position effects in patients with geriatric depression (N=20) or AD (N=32) and in elderly controls (N=18). Groups were compared on two measures of serial position of the California Verbal Learning Test (CVLT), scaled scores and regional scores. Newly devised regional scores measure the percentage of items recalled as a function of the possible number of items presented from three regions of the list. Regional scores significantly differentiated depressed from control groups, with reduction of recalled items from the middle region. Scaled scores distinguished the depression from the AD groups on primacy and recency regions, with the characteristic recency effect seen in the AD group. Deficits in regional scores of the middle region are discussed in the context of lower resources in depression.

Entities:  

Mesh:

Year:  2003        PMID: 14500116     DOI: 10.1016/s0165-1781(03)00163-x

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  17 in total

1.  Serial position effects in mild cognitive impairment.

Authors:  Diane B Howieson; Nora Mattek; Adriana M Seeyle; Hiroko H Dodge; Dara Wasserman; Tracy Zitzelberger; Kaye Jeffrey
Journal:  J Clin Exp Neuropsychol       Date:  2010-12-02       Impact factor: 2.475

2.  The recency ratio as predictor of early MCI.

Authors:  Davide Bruno; Rebecca L Koscik; John L Woodard; Nunzio Pomara; Sterling C Johnson
Journal:  Int Psychogeriatr       Date:  2018-04-18       Impact factor: 3.878

3.  The recency ratio is associated with reduced CSF glutamate in late-life depression.

Authors:  Davide Bruno; Jay Nierenberg; Thomas B Cooper; Charles R Marmar; Henrik Zetterberg; Kaj Blennow; Kenji Hashimoto; Nunzio Pomara
Journal:  Neurobiol Learn Mem       Date:  2017-03-18       Impact factor: 2.877

4.  Predicting Early Mild Cognitive Impairment With Free Recall: The Primacy of Primacy.

Authors:  Deborah Talamonti; Rebecca Koscik; Sterling Johnson; Davide Bruno
Journal:  Arch Clin Neuropsychol       Date:  2020-02-20       Impact factor: 2.813

5.  Now you make false memories; now you do not: the order of presentation of words in DRM lists influences the production of the critical lure in Alzheimer's disease.

Authors:  Christelle Evrard; Anne-Laure Gilet; Fabienne Colombel; Elodie Dufermont; Yves Corson
Journal:  Psychol Res       Date:  2016-12-03

6.  Machine learning amplifies the effect of parental family history of Alzheimer's disease on list learning strategy.

Authors:  Timothy S Chang; Michael H Coen; Asenath La Rue; Erin Jonaitis; Rebecca L Koscik; Bruce Hermann; Mark A Sager
Journal:  J Int Neuropsychol Soc       Date:  2012-02-10       Impact factor: 2.892

7.  Visual short-term memory binding in Alzheimer's disease and depression.

Authors:  Mario A Parra; Sharon Abrahams; Robert H Logie; Sergio Della Sala
Journal:  J Neurol       Date:  2010-02-17       Impact factor: 4.849

8.  Qualitative aspects of learning, recall, and recognition in dementia.

Authors:  Neelima Ranjith; P S Mathuranath; Gangadhar Sharma; Aley Alexander
Journal:  Ann Indian Acad Neurol       Date:  2010-04       Impact factor: 1.383

9.  Effect of parental family history of Alzheimer's disease on serial position profiles.

Authors:  Asenath La Rue; Bruce Hermann; Jana E Jones; Sterling Johnson; Sanjay Asthana; Mark A Sager
Journal:  Alzheimers Dement       Date:  2008-07       Impact factor: 21.566

10.  Alzheimer's disease, but not ageing or depression, affects dual-tasking.

Authors:  Reiner Kaschel; Robert H Logie; Miguel Kazén; Sergio Della Sala
Journal:  J Neurol       Date:  2009-06-19       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.